Drug interactions with the nonsedating antihistamines

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Drug Safety

Background:

• Nonsedating antihistamines are widely used for allergic conditions.
• Previous generations of antihistamines caused sedation, necessitating the development of non-sedating alternatives.
• Drug-drug interactions (DDIs) involving medications are a significant concern in patient safety.

Purpose of the Study:

• To review known drug-drug interactions associated with nonsedating antihistamines.
• To identify which nonsedating antihistamines pose the highest risk for serious adverse events.
• To provide clinicians with information to predict and prevent potentially fatal drug interactions.

Main Methods:

• Literature review of published studies on nonsedating antihistamines and their interactions.
• Analysis of case reports and clinical trial data regarding adverse events.
• Pharmacokinetic and pharmacodynamic assessments of drug interactions.

Main Results:

• Terfenadine and astemizole have well-documented, potentially fatal interactions with macrolide antibiotics and azole antifungals (itraconazole, ketoconazole).
• These interactions can lead to serious cardiac adverse effects.
• Fexofenadine and loratadine appear to have a lower potential for such severe drug-drug interactions.

Conclusions:

• Clinicians must be aware of the significant interaction risks associated with certain nonsedating antihistamines.
• Fexofenadine and loratadine are generally considered safer choices regarding life-threatening drug interactions.
• Careful medication review and patient counseling are essential to prevent adverse drug events.